Log in
NASDAQ:PRNB

Principia Biopharma Earnings Date, Estimates & History

$100.05
+0.06 (+0.06 %)
(As of 09/17/2020 12:00 AM ET)
Add
Compare
Today's Range
$99.90
Now: $100.05
$100.18
50-Day Range
$83.49
MA: $95.22
$101.07
52-Week Range
$25.35
Now: $100.05
$101.89
Volume538,905 shs
Average Volume719,515 shs
Market Capitalization$3.32 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.86

Earnings

Principia Biopharma (NASDAQ:PRNB) Earnings Information

Principia Biopharma last released its earnings results on August 6th, 2020. The reported $0.31 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($1.03) by $1.34. The business earned $50 million during the quarter, compared to analyst estimates of $50 million. Principia Biopharma has generated ($2.09) earnings per share over the last year. Principia Biopharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 3rd, 2020 based off prior year's report dates.

Principia Biopharma Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Principia Biopharma (NASDAQ:PRNB) Earnings Estimates

2020 EPS Consensus Estimate: ($4.08)
2021 EPS Consensus Estimate: ($4.31)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20201($1.36)($1.36)($1.36)
Q3 20201($1.12)($1.12)($1.12)
Q4 20201($1.60)($1.60)($1.60)
Q1 20211($1.64)($1.64)($1.64)
Q2 20211($1.37)($1.37)($1.37)
Q3 20211$0.04$0.04$0.04
Q4 20211($1.34)($1.34)($1.34)

Principia Biopharma (NASDAQ PRNB) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
11/3/2020
(Estimated)
       
8/6/20206/30/2020($1.03)$0.31$0.31$50.00 million$50.00 millionN/A
5/6/20203/31/2020($0.79)($0.99)($0.99)$4.93 millionN/A
3/10/202012/31/2019($0.78)($0.80)($0.80)$4.35 millionN/A
11/5/2019Q3($0.85)($0.93)($0.93)$5.32 millionN/A
8/8/2019Q2 2019($0.6530)$0.28$0.28$6.16 million$30.00 millionN/A
5/7/2019Q1($0.6180)($0.57)($0.57)$8.00 million$5.16 millionN/A
3/19/2019Q4($0.3080)$0.37$0.37$13.70 million$26.14 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 9/18/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.